Targeted delivery of TGF-β mRNA to murine lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers

Current clinical strategies for the delivery of pulmonary therapeutics to the lung are primarily targeted to the upper portions of the airways, such as treatment with nebulized instillation and inhalation. However, targeted delivery to the lower regions of the lung is necessary for the treatment of parenchymal lung injury and disease. Here, we show the development of an mRNA therapeutic for the lower lung in mice using one-component Ionizable Amphiphilic Janus Dendrimers as a delivery vehicle. We deliver an anti-inflammatory cytokine mRNA, transforming growth factor-beta, to produce transient protein expression in the lower regions of the lung. This study highlights a method for precise, effective, and safe delivery of TGF-β mRNA to the lung in mice. This delivery system offers a promising approach for targeting therapeutics to the specific tissues, a strategy necessary to fill the current clinical gap in treating parenchymal lung injury and disease.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-02-21
DOI
https://doi.org/10.1038/s41467-025-56448-y
Citations
32
Primary Topic
Inhalation and Respiratory Drug Delivery
Type
article
Field-Weighted Citation Impact
48.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeted delivery of TGF-β mRNA to murine lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers

Devendra S. Maurya, Andrew J. Gow, Emily Stevenson, Erin K. Reagan et al.
32 citations
Nature Communications
Inhalation and Respiratory Drug Delivery
48.59
article

Targeted delivery of TGF-β mRNA to murine lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers

Devendra S. Maurya, Andrew J. Gow, Emily Stevenson, Erin K. Reagan, Nathan Ona, Rachel Sun, Changjiang Guo, Elena N. Atochina‐Vasserman, J. Meshanni, Елена Владимировна Абрамова, Drew Weissman, Ishana Baboo, Melissa L. Wilkinson, Virgil Percec, Dapeng Zhang, Yongsheng Li, Yuzi Yang, Liuyan Pan
article en
32 citations

Abstract

Current clinical strategies for the delivery of pulmonary therapeutics to the lung are primarily targeted to the upper portions of the airways, such as treatment with nebulized instillation and inhalation. However, targeted delivery to the lower regions of the lung is necessary for the treatment of parenchymal lung injury and disease. Here, we show the development of an mRNA therapeutic for the lower lung in mice using one-component Ionizable Amphiphilic Janus Dendrimers as a delivery vehicle. We deliver an anti-inflammatory cytokine mRNA, transforming growth factor-beta, to produce transient protein expression in the lower regions of the lung. This study highlights a method for precise, effective, and safe delivery of TGF-β mRNA to the lung in mice. This delivery system offers a promising approach for targeting therapeutics to the specific tissues, a strategy necessary to fill the current clinical gap in treating parenchymal lung injury and disease.

Nature CommunicationsVol. 16(1)
Rutgers, The State University of New Jersey (US), East China University of Science and Technology (CN), Environmental and Occupational Health Sciences Institute (US), Penn Center for AIDS Research (US), University of Pennsylvania (US)
National Institute of Environmental Health Sciences
Openalex Percentile: Top 0%
Inhalation and Respiratory Drug Delivery
48.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.